If oxidized LDL immune complexes are relevant in diabetic atherosclerosis, shouldn't they also be relevant in diabetic nephropathy?

Clinical Immunology

Volumn 139, Issue 3, 2011, Pages 233-234

  Quigg, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIGEN ANTIBODY COMPLEX; ATHEROSCLEROSIS; CELL ACTIVATION; CELL CULTURE; DIABETIC NEPHROPATHY; EDITORIAL; GLOMERULOSCLEROSIS; HUMAN; MESANGIUM CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANTIGEN-ANTIBODY COMPLEX; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; LIPOPROTEINS, LDL;

EID: 79955957093     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.03.012     Document Type: Editorial

References (8)

1. Abdelsamie S.A., Li Y., Huang Y., Lee M.-H., Klein R.L., Virella G., Lopes-Virella M.F. Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III. Clin. Immunol. 2011, 139:258-266.
2. Lee H.S., Kim B.C., Kim Y.S., Choi K.H., Chung H.K. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int. 1996, 50:1582-1590.
3. Lopes-Virella M.F., Baker N.L., Hunt K.J., Lachin J., Nathan D., Virella G. Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes. Atherosclerosis 2011, 214:462-467.
4. Lopes-Virella M.F., Virella G. Clinical significance of the humoral immune response to modified LDL. Clin. Immunol. 2010, 134:55-65.
5. Lopes-Virella M.F., Carter R.E., Gilbert G.E., Klein R.L., Jaffa M., Jenkins A.J., Lyons T.J., Garvey W.T., Virella G. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care 2008, 31:2006-2012.
6. Lopes-Virella M.F., McHenry M.B., Lipsitz S., Yim E., Wilson P.F., Lackland D.T., Lyons T., Jenkins A.J., Virella G. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis 2007, 190:359-369.
7. Virella G., Carter R.E., Saad A., Crosswell E.G., Game B.A., Lopes-Virella M.F. Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy. Clin. Immunol. 2008, 127:394-400.
8. Lee H.S., Kim Y.S. Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int. 1998, 54:848-856.